Search

Your search keyword '"Raman, Rakesh"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Raman, Rakesh" Remove constraint Author: "Raman, Rakesh"
46 results on '"Raman, Rakesh"'

Search Results

2. Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)

4. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

5. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

10. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

11. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

12. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

16. Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications

17. Relevance of adjuvant chemotherapy in elderly patients with low rectal tumors.

21. Development and validation of blood-based predictive biomarkers for response to PD-(L)-1 checkpoint inhibitors: evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indications

24. Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies

25. Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia

26. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

27. Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies.

28. Abstract 3023: Exposure versus efficacy/safety of acalabrutinib and its pharmacologically active metabolite, ACP-5862, for the treatment of chronic lymphocytic leukemia

30. Timing of radiotherapy after radical prostatectomy (RADICALS-RT):a randomised, controlled phase 3 trial

32. Medical Management of Renal Cell Cancer

33. Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma

34. Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

35. Phase 2 study of acalabrutinib in ibrutinib (IBR)-intolerant patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

36. Oncologist-led BRCAcounselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

38. Obstacles to Inclusive Primary Education: A Demand Side Perspective

40. Inter- District Disparity in Health Care Facility and Education: A Case of Uttar Pradesh

41. Knowledge stories for children: Raman's tech tale series, book 2

42. Nonlinear sliding surface based adaptive sliding mode control for industrial emulator.

43. Financial Inclusion in Uttar Pradesh and Bihar.

44. RURAL NON-FARM ECONOMY IN INDIA: A STUDY OF UTTAR PRADESH.

45. Temperature-Dependent Small-Angle X-Ray Scattering from Polyethylene

46. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Catalog

Books, media, physical & digital resources